22nd Apr 2008 07:01
Sinclair Pharma PLC22 April 2008 Sinclair Pharma plc (the "Company") The Company was informed on 21st April 2008 that Dr. Michael Flynn, ChiefExecutive Officer, acquired 3,000 ordinary shares of 1p each in the Company ("Ordinary Shares") at an average price of 40.95 pence per share on 21st April2008. Following this acquisition of Ordinary Shares Dr. Flynn has an interest in atotal of 10,053,000 Ordinary Shares equalling approximately 10.8 per cent. ofthe issued share capital in the Company. For further information please contact: Sinclair Pharma plc Tel: +44 (0) 1483 410 600Jerry Randall, CFO This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma